| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| METHYLERGONOVINE
| METHYLERGONOVINE | VARIOUS | ORAL INJECTION | Cmax 9.56 NANOMOLAR Tmax 1.12 HOUR F 60 PERCENT VD 56.1 LITER Cl 14.4 LITER / HOUR HT 3.39 HOUR | ALPHA-1 ADRENERGIC RECEPTOR SEROTONERGIC (5-HT2) RECEPTOR PDB 6DRY (STRUCTURAL DETERMINANTS OF ACTIVATION AND BIASED AGONISM AT THE 5-HT2B RECEPTOR) LIGAND CODE = H8D (link to the list of PDB complexes) Download experimental 3D coordinates of H8D with added hydrogens | DOPAMINE D1 RECEPTOR ANTAGONIST CHEMBL2056 DOPAMINE D1 RECEPTOR P21728 D(1A) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA | |||
